| 【1】Yoshida A, Rzhetsky A, et al. Human aldehyde dehydrogenase gene family [J]. European Journal of Biochemistry. 1998, 251(3) : 549-557【2】Vasilis Vasiliou,Daniel W. Nebert. Analysis and update of the human aldehyde dehydrogenase ( ALDH ) gene family [J]. Human Genomics. 2005, 2(2) :138-143【3】Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature. 2001,414(6859)：105—111.【4】Shan Deng, Xiaojun Yang, Heini Lassus, et al. Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1) in Human Epithelial Cancers. PloS One, 2010, 5(4): e10277.【5】GINESTIER C, HUR M H, CHARAFE-JAU FFRETE, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predict or of poor clinical outcome[J] .Cell Stem Cell, 2007, 1(5) : 555-567.【6】Tomonori Tanei, Koji Morimoto, Kenzo Shimazu, et al. Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers. Clin Cancer Res. 2009; 15: 4234-4241.【7】Erika Resetkova,Jorge S. Reis-Filho,Rohit K. Jain. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat. 2010, 123:97–108.【8】Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino F, et al. ALDH1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res. 2010; 16(1): 45–55.【9】Marise R. Heerma van Voss, Petra van der Groep,Joost Bart. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. Cellular Onc. (2011) 34:3–10.【10】Veronique Neumeister, Seema Agarwal,Jennifer Bordeaux. In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis. The American Journal of Pathology, 2010, 176: 2131-2138.【11】Bhuvanesh Dave, Jenny Chang. Treatment Resistance in Stem Cells and Breast Cancer. J Mammary Gland Biol Neoplasia. 2009, 14: 79-82.【12】Huang EH , Hynes MJ, Zhang T, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulat ion during colon tumorigenesis [J]. Cancer Res, 2009, 69(8) : 3382- 3389.【13】Matilde Todaro, Maria Giovanna Francipane, Jan Paul Medema,et al. Colon Cancer Stem Cells: Promise of Targeted Therapy. GASTROENTEROLOGY 2010;138:2151–2162【14】Ginestier C, Hur MH, Charafe Jauffret E, et al. ALDH 1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome [J].Cell Stem Cell, 2007,1 (5):555-567【15】Bin Chang, Guangzhi Liu, Fenxia Xue, et al. ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers. Mod Pathol. 2009 June ; 22(6): 817–823.【16】Christoph Kahlert, Frank Bergmann, Janine Beck. Low expression of aldehyde deyhdrogenase 1A1(ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. BMC Cancer. 2011, 11:275.【17】Matthew R. Clay, Mark Tabor, et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase [J]. Head Neck. 2010 September : 1195-1201【18】Yao T, Chen Q, et al. The expression of ALDH1 in cervical carcinoma. Medical Science Monitor. 2011, 17:8 (HY21-HY26).【19】Yu-Chih Chen , Yi-Wei Chen ,et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochemical and Biophysical Research Communications.2009 , 385: 307-313【20】Visus C, Ito D, Amoscato A, et al. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell defined tumor antigen in squamous cell carcinoma of the head and neck [J].Cancer Res. 2007, 67(21): 10538-10545.【21】Carolina M. Sterz, Carolin Kulle et al. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9[J]. Oral Oncology. 2010,46: 116-122.【22】Yu-Chih Chen ,Charn-Jung Chang, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1 [J]. Oral Oncology. 2010, 46: 158–165.【23】Wen-Liang Loa, Yueh Chien, Guang-Yuh Chiou, et al. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous Cell carcinoma-derived cancer stem cells.Biomaterials. 2012 May;33(14):3693-709.【24】Jing Xu, Susan Müller, Sreenivas Nannapaneni, et al. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer[J]. Eur J Cancer. 2012 Feb 15. |
